A UPL is the maximum reimbursement certain payers can provide pharmacies and providers for a drug. A UPL caps what a payer ...

Admilparant 60 mg met the ALOFT-IPF primary end point, significantly improving FVC change vs placebo at 52 weeks in ...

Dyshidrotic eczema behaves differently from other forms of hand eczema in ways that matter for how it is worked up and ...

Cancer survivors are living longer, but longer survival brings a new pressing question: who helps them live well afterward?

When Erica Plybeah launched MedHaul in 2017, she didn’t just think medical transportation was a barrier to care. She’d lived ...

Postpartum navigation missed its primary goal but raised postpartum visits and primary care use among Medicaid-insured ...

Early MASH risk stratification, drug choice, and aligned coverage could improve outcomes, explained Zobair Younossi, MD.

A 39-year-old woman in Franklin County, Pennsylvania, died after a recent measles diagnosis in what would be the sixth ...

Nogapendekin alfa inbakicept-pmln (Anktiva; ImmunityBio Inc) given with Bacillus Calmette-Guérin (BCG) is now the first ...

Iberdomide (Zenbexus; Bristol Myers Squibb) in combination with daratumumab and dexamethasone (ZDd) demonstrated a statistically significant improvement in the dual-primary end po ...

D’Amico concluded that remigromig is the first biologic with a novel mechanism of action that demonstrated a noninferior ...

Eliot F. Battle, MD, cofounder and CEO of Cultura Dermatology & Laser Center in Washington, DC, and cochair of Skin of Color ...